Elevated serum phosphorus is a strong independent risk factor for mortality in maintenance hemodialysis (MHD) patients, so controlling serum phosphorus levels is a priority (Kidney Int. 2006;70: ...

People on dialysis need about 8-10 ounces of high-protein food like meat, fish, poultry, or eggs every day. While nuts, seeds, and legumes also have protein, you’ll need to limit them because ...

For the more than half a million Americans receiving dialysis, treatment doesn't end when they leave the center. Many patients manage complex medicat ...

A study of Japanese dialysis patients demonstrated that a combination of oral vitamin D and a phosphorus binder is associated with lower mortality. The study, by Tsuneo Konta, MD, PhD, Associate ...

Ardelyx-stock News for Ardelyx Ardelyx Receives Complete Response Letter from U.S. FDA for New Drug Application for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis ...

An FDA advisory committee voted 9-4 in favor of the use of Xphozah as a monotherapy for controlling serum phosphorus levels in adults with chronic kidney disease on dialysis.Members of the ...

Tenapanor, a novel agent that has been submitted to the US Food and Drug Administration (FDA) for approval for the treatment of hyperphosphatemia in patients undergoing dialysis, moved a step ...

Ardelyx is advancing tenapanor, a novel product candidate to control serum phosphorus in adult patients with CKD on dialysis, for which the company's NDA is currently under review by the FDA.

In this episode of The Expert Series, LFA’s Senior Communication Strategist Duane Peters talks with Melanie Betz of University of Chicago. Betz, a member of the American Kidney Fund dietician advisory ...